Sanofi ( SNY) - Key Metrics
SNY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.14 | $0.14 | $1.98 | $0.87 |
| 2026Q1 | $4.67 | $0.67 | $0.70 | $0.70 |
| 2025Q4 | $5 | -$0.33 | $1.41 | $0.65 |
| 2025Q3 | $5.41 | $1.15 | $1.54 | $1.89 |
| 2025Q2 | $4.35 | $1.60 | $0 | $0 |
SNY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 1463.79% | 66.68 |
| 2026Q1 | 0% | 15.55 |
| 2025Q4 | 0% | -6.97 |
| 2025Q3 | 0% | 8.74 |
| 2025Q2 | 116.67% | 6.42 |
SNY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.33% | 5.62% |
| 2026Q1 | 1.68% | 0% |
| 2025Q4 | 1.58% | 0% |
| 2025Q3 | 4.69% | 0% |
| 2025Q2 | 0% | 4.54% |
SNY
Price: $40.19
Dividend Yield: 6.12%
Forward Dividend Yield: 6.05%
Payout Ratio: 109.54%
Dividend Per Share: 2.42 USD
Earnings Per Share: 1.86 USD
P/E Ratio: 22.95
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: France
Volume: 337528
Ebitda: 1.5 billionMarket Capitalization: 94.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 24
DGR3: 4.59%
DGR5: 5.40%
DGR10: 3.30%
DGR20: 30.00%